Sarah Read - Concepedia

Author

Sarah Read

National Institute of Allergy and Infectious Diseases

Also Known As

Bosch, Ronald J., Kevin Barrett, S Read, S. G. Read, S. Read, Sarah Read, Stacey J Adam, Stacey J. Adam, Wiegand, Ann, William Erhardt

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

National Institute of Allergy and Infectious Diseases Harvard University National Institutes of Health University of North Carolina at Chapel Hill Social and Scientific Systems (United States)

About

Sarah Read is an author at National Institute of Allergy and Infectious Diseases specializing in medicine, inflammation, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	532
2	Social Sciences	2	2	1.1K
3	Behavioral Sciences	1	1	1.1K
4	Cognitive Science	1	1	1.1K
5	Emergency Medicine	1	1	19

Sarah Read

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Attention alters appearance Marisa Carrasco, Sam Ling, Sarah Read Nature Neuroscience Behavioral SciencesCognitive ScienceEye TrackingSelective AttentionAttention	2004	1.1K
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial Rajesh T. Gandhi, Lu Zheng, Ronald J. Bosch, PLoS Medicine	2010	306
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	289
No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1–Infected Patients Receiving Antiretroviral Therapy Rajesh T. Gandhi, Robert W. Coombs, Ellen S. Chan, JAIDS Journal of Acquired Immune Deficiency Syndromes	2011	107
Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study. Frances A. Shepherd, Ronald Beaulieu, Karen Gelmon, Journal of Clinical Oncology	1998	79
Immune Activation in the Pathogenesis of Treated Chronic HIV Disease: A Workshop Summary Susan Plaeger, Brenda S. Collins, Runa Musib, AIDS Research and Human Retroviruses Immune ActivationImmunologyHuman Immunodeficiency VirusImmunotherapyImmune System	2011	63
The NIH-led research response to COVID-19 Francis S. Collins, Stacey J. Adam, Christine M. Colvis, Science	2023	45
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1 Jeffrey M. Jacobson, Steven E. Bosinger, Minhee Kang, AIDS Research and Human Retroviruses Immune ActivationTlr LigandsImmune RegulationImmunologyAntiviral Drug	2016	41
Eltoprazine in aggressive mentally handicapped patients P. de Koning, Michael Mak, M. Hugo de Vries, International Clinical Psychopharmacology Aggressive BehaviourChronic Eltoprazine TreatmentTherapeutic EffectDrug IntolerancePsychiatry	1994	27

Page 1